WO2010136841A3 - Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof - Google Patents
Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof Download PDFInfo
- Publication number
- WO2010136841A3 WO2010136841A3 PCT/IB2009/006039 IB2009006039W WO2010136841A3 WO 2010136841 A3 WO2010136841 A3 WO 2010136841A3 IB 2009006039 W IB2009006039 W IB 2009006039W WO 2010136841 A3 WO2010136841 A3 WO 2010136841A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- genome
- variants
- integrating virus
- meganuclease variants
- variants cleaving
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The present invention relates to variants of the meganuclease l-CreI which are characterized in that they are able to cleave a DNA target sequen from a non-integrating virus (NIV) genome. The present invention also relat to rational methods to generate such l-Crel variants and the use of the variants as research and diagnostic reagents, as well as medicamen comprising these I-Crel variants for the treatment of NIV infections.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2009/006039 WO2010136841A2 (en) | 2009-05-26 | 2009-05-26 | Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof |
PCT/IB2010/052340 WO2010136981A2 (en) | 2009-05-26 | 2010-05-26 | Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
US13/322,266 US20120171191A1 (en) | 2009-05-26 | 2010-05-26 | Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
EP10726296A EP2435560A2 (en) | 2009-05-26 | 2010-05-26 | Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
US14/744,668 US20150315557A1 (en) | 2009-05-26 | 2015-06-19 | Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2009/006039 WO2010136841A2 (en) | 2009-05-26 | 2009-05-26 | Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010136841A2 WO2010136841A2 (en) | 2010-12-02 |
WO2010136841A3 true WO2010136841A3 (en) | 2011-03-17 |
Family
ID=41258112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2009/006039 WO2010136841A2 (en) | 2009-05-26 | 2009-05-26 | Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010136841A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3526323B1 (en) | 2016-10-14 | 2023-03-29 | Precision Biosciences, Inc. | Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome |
TW201945388A (en) | 2018-04-12 | 2019-12-01 | 美商精密生物科學公司 | Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis B virus genome |
EP4069729A1 (en) | 2019-12-06 | 2022-10-12 | Precision BioSciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004067753A2 (en) * | 2003-01-28 | 2004-08-12 | Cellectis | Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
WO2007047859A2 (en) * | 2005-10-18 | 2007-04-26 | Precision Biosciences | Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
WO2007057781A2 (en) * | 2005-10-25 | 2007-05-24 | Cellectis | Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof. |
WO2008059382A2 (en) * | 2006-11-14 | 2008-05-22 | Cellectis | Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof |
WO2008102274A2 (en) * | 2007-02-20 | 2008-08-28 | Cellectis | Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof |
WO2009013622A2 (en) * | 2007-07-23 | 2009-01-29 | Cellectis | Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
-
2009
- 2009-05-26 WO PCT/IB2009/006039 patent/WO2010136841A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004067753A2 (en) * | 2003-01-28 | 2004-08-12 | Cellectis | Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
WO2007047859A2 (en) * | 2005-10-18 | 2007-04-26 | Precision Biosciences | Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
WO2007057781A2 (en) * | 2005-10-25 | 2007-05-24 | Cellectis | Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof. |
WO2008059382A2 (en) * | 2006-11-14 | 2008-05-22 | Cellectis | Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof |
WO2008102274A2 (en) * | 2007-02-20 | 2008-08-28 | Cellectis | Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof |
WO2009013622A2 (en) * | 2007-07-23 | 2009-01-29 | Cellectis | Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
Non-Patent Citations (5)
Title |
---|
ARNOULD S ET AL: "Engineering of Large Numbers of Highly Specific Homing Endonucleases that Induce Recombination on Novel DNA Targets", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 355, no. 3, 20 January 2006 (2006-01-20), pages 443 - 458, XP024950505, ISSN: 0022-2836, [retrieved on 20060120] * |
CHEVALIER B ET AL: "Flexible DNA Target Site Recognition by Divergent Homing Endonuclease Isoschizomers I-CreI and I-MsoI", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 329, no. 2, 30 May 2003 (2003-05-30), pages 253 - 269, XP004454255, ISSN: 0022-2836 * |
PÂQUES FRÉDÉRIC ET AL: "Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy", CURRENT GENE THERAPY, BENTHAM SCIENCE PUBLISHERS LTD, NL, vol. 7, no. 1, 1 February 2007 (2007-02-01), pages 49 - 66, XP002493370, ISSN: 1566-5232 * |
ROSEN LAURA E ET AL: "Homing endonuclease I-CreI derivatives with novel DNA target specificities", NUCLEIC ACIDS RESEARCH, vol. 34, no. 17, October 2006 (2006-10-01), pages 4791 - 4800, XP002554264, ISSN: 0305-1048 * |
SMITH JULIANNE ET AL: "A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 34, no. 22, 27 November 2006 (2006-11-27), pages E149 - 1, XP002457876, ISSN: 0305-1048 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010136841A2 (en) | 2010-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4349404A3 (en) | Respiratory virus vaccines | |
WO2010115016A3 (en) | Nucleic acid preparation compositions and methods | |
WO2011008495A3 (en) | Arginase formulations and methods | |
WO2010018563A3 (en) | Compositions and methods for the prognosis of lymphoma | |
WO2010127304A3 (en) | Sequencing methods | |
WO2011106766A3 (en) | Modified proteins and methods of making and using same | |
WO2008143627A3 (en) | Targeted whole genome amplification method for identification of pathogens | |
EP4279610A3 (en) | Ribonucleic acid purification | |
WO2008124148A3 (en) | Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease | |
WO2008094254A3 (en) | Methods and compositions for the treatment of cancer or other diseases | |
WO2007081974A3 (en) | Viral hepatitis treatment | |
WO2010148039A3 (en) | Methods and compositions for long fragment read sequencing | |
WO2013039861A3 (en) | Engineered nucleic acids and methods of use thereof | |
WO2012045082A3 (en) | Engineered nucleic acids and methods of use thereof | |
WO2010122367A3 (en) | Meganuclease variants cleaving the genomic insertion of a virus and uses thereof | |
IN2012DN00403A (en) | ||
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
EP2274442A4 (en) | Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same | |
WO2008057550A3 (en) | Stabilization of vaccines by lyophilization | |
WO2010039802A3 (en) | Methods and compositions for isolating nucleic acid | |
WO2012017329A8 (en) | Method for targeted genomic events in algae | |
WO2010021717A3 (en) | Hcv protease inhibitors | |
WO2008085990A3 (en) | Systems for genome selection | |
WO2014018601A3 (en) | New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins | |
WO2012037116A3 (en) | Genetic variations associated with common variable immunodeficiency (cvid) and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09785963 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09785963 Country of ref document: EP Kind code of ref document: A2 |